You have requested a machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Neither SPIE nor the owners and publishers of the content make, and they explicitly disclaim, any express or implied representations or warranties of any kind, including, without limitation, representations and warranties as to the functionality of the translation feature or the accuracy or completeness of the translations.
Translations are not retained in our system. Your use of this feature and the translations is subject to all use restrictions contained in the Terms and Conditions of Use of the SPIE website.
16 February 2010Optofluidic biosensing for the study of disease at the molecular level
Despite decades of gains in biotechnology, currently much remains unknown about the molecular mechanisms of a
number of deadly diseases. New tools are needed to speed discovery at the molecular level and to mitigate the
complexity of studying the systems biology of disease. In the last decade, a number of advancements have been made
in photonic biosensing aimed at developing a new generation of technologies for the study and early detection of
disease. Label-free photonic biosensing techniques such as surface plasmon resonance imaging (SPRI), nanoporous
silicon waveguides, interferometry, and optical resonators have achieved detection limits on par with conventional
techniques while decreasing the size of the biosensing element and reducing the number of steps involved in the
biosensing procedure. In addition, surface enhanced Raman spectroscopy (SERS) has been shown to detect molecules
in extremely low numbers, even single molecules.
In parallel to the development of a new generation of photonic biosensing techniques, advanced microfluidic
technologies have emerged. The last decade has seen the development of automated micro-valves and micro-pumps,
particle sorting, concentration gradient generation, and sample mixing. Also, photonic components, including
waveguides and lenses, have been fabricated from soft-lithography materials. Synthesizing advanced microfluidic
techniques with the new generation of photonic biosensing is likely to be the key to increasing throughput by increasing
automation, decreasing equipment costs, and enabling multiplexing. This report will review examples of recent work in
optofluidic biosensors and will discuss the opportunities for advancing research related to disease at the molecular level
utilizing optofluidic biosensing technologies.
Ian M. White
"Optofluidic biosensing for the study of disease at the molecular level", Proc. SPIE 7606, Silicon Photonics V, 760609 (16 February 2010); https://doi.org/10.1117/12.840877
The alert did not successfully save. Please try again later.
Ian M. White, "Optofluidic biosensing for the study of disease at the molecular level," Proc. SPIE 7606, Silicon Photonics V, 760609 (16 February 2010); https://doi.org/10.1117/12.840877